1 Result(s)

Chapter and Conference Paper

Evaluation of In Vivo Natural Killer and Lymphokine-Activated Killer Cell Activity in Patients Treated with High-Dose Interleukin-2 and Adoptive Transfer of Autologous LAK Cells

A substantial number of Phase I and Phase II clinical trials of interleukin-2 (IL-2) alone or combined with adoptive transfer of lymphokine-activated killer (LAK) cells in the treatment of cancer patients had ...

J. Walewski, E. Paietta, J. Dutcher… in Cytokines in Hemopoiesis, Oncology, and AI… (1990)